Evidence. Care. Accountability.Contact the desk
Our standards

Research explained

BPC-157 versus a thymosin preparation after tendon repair

Small rat groups and one time point do not establish benefit of a marketed human stack.

On this page

Evidence dossier

The report behind the claim

The thymosin group reached significant biomechanical benefit; BPC-only total histology scores did not reach significance, and the combination did not establish an additive advantage. Small rat groups and one time point do not establish benefit of a marketed human stack.

Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.

Design
Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
Participants or model
32 male rats after standardized Achilles transection and repair
Endpoint
Four-week load to failure and tissue scores
Finding on record
The thymosin group reached significant biomechanical benefit; BPC-only total histology scores did not reach significance, and the combination did not establish an additive advantage.
Limits of inference
Small rat groups and one time point do not establish benefit of a marketed human stack.
Read the publication

The experiment in view

The study used 32 male rats after standardized Achilles transection and repair. Its principal measures were four-week load to failure and tissue scores. The thymosin group reached significant biomechanical benefit; BPC-only total histology scores did not reach significance, and the combination did not establish an additive advantage.

Reading the result closely

A numerical difference and a statistically supported contrast are not interchangeable. Reading only the paper's optimistic conclusion would miss which group met which endpoint. The authors' TB-500 terminology also needs product-identity scrutiny before a retail blend is compared.

The boundary of the finding

Small rat groups and one time point do not establish benefit of a marketed human stack.

Related evidence, kept separate

BPC-157 after a rat muscle-crush injury examines macroscopic and microscopic healing, function and enzyme activity. Here, the measured endpoint was four-week load to failure and tissue scores. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with The rabbit bone-defect paper: continuity is not a human fracture outcome appraisal.

On the record

The documents supporting this report.

  1. BPC-157 versus a thymosin preparation after tendon repair — original indexed research

The continuing record

More from the report

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review